• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press releases

Marking World Chagas Day for the first time to help give visibility to this neglected disease

Home > Press releases

Marking World Chagas Day for the first time to help give visibility to this neglected disease

Woman standing in a street in Colombia
From a world under lockdown due to the coronavirus pandemic — 13 Apr 2020

Starting this year, April 14th will serve to give visibility in the global health agenda to the challenges faced by people affected by Chagas disease, most of whom live in low-income contexts and highly vulnerable health conditions.

For the first time in the 111 years since the first case of Chagas disease was diagnosed in humans, we are celebrating World Chagas Day, which was established by the World Health Organization (WHO) on April 14th to remind us of the challenges faced by those affected by this neglected disease.

Well aware that the COVID-19 pandemic requires maximum attention at this critical moment, the aim of marking this first-ever World Chagas Day is to remember the people affected by this disease, which has historically been given low priority in health agendas. This is all the more important at a time when many of those suffering from Chagas disease are amongst the population groups vulnerable to the COVID-19 pandemic.

Chagas disease is caused by the parasite Trypanosoma cruzi, which is mostly transmitted through the feces of the triatomine bug. This bug is commonly known under several names such as “vinchucas”, “chinches”, or “pitos”, and  it is found in the southern United States and all over Latin America. Other common transmission routes are from mother to child during pregnancy, oral, through blood transfusions, and organ transplants. The different transmission routes, together with migratory flows over the last few decades, have made the disease a global challenge.

Approximately 30% of those who become infected with Chagas disease develop serious complications that mainly affect the heart and also lead to neurological and gastrointestinal disorders at a lesser level.

It is estimated that at least 7 million people are infected worldwide. Every year, close to 9,000 children are born with the parasite Trypanosoma cruzi, which causes the death of more than 12,000 people each year. It is also estimated that more than 75 million people worldwide are at risk of becoming infected. As a result, diagnosis and early treatment are crucial, with current treatments achieving very good results.

The International Federation of Associations of People Affected by Chagas disease (FINDECHAGAS) is calling for health authorities in countries where cases have been detected ‘to maintain prevention programmes so that to ensure that as many people as possible are protected’. They also highlight the need to ‘give priority to attention and treatment to people with a positive result, given that, in many cases, this will make a difference between staying healthy or falling ill, or between life and death’.

World Chagas Day was established last year during the World Health Assembly to respond to a request presented by FINDECHAGAS to reverse more than a hundred years of silence and lack of visibility around Chagas disease.

The current COVID-19 pandemic is challenging commitments and support to health systems and universal health coverage leaving nobody behind. To end Chagas disease as a public health issue, efforts must be intensified to control all the transmission routes, strengthen and improve current diagnostics and treatments, develop new tools, and extend comprehensive health coverage to all people living with the disease or at risk of getting infected. At the same time, efforts must be made to promote communication and develop disease awareness.

To these ends, it is vital that over the next decade, policymakers and funders work more closely and willingly with the community of people affected by Chagas disease, researchers, organizations, and health professionals fighting to overcome the challenges posed by Chagas disease.

As FINDECHAGAS reminds, ‘it is of utmost importance that people living with Chagas disease receive the information needed for adequate prevention and the appropriate attention when necessary, even more during the COVID-19 pandemic. For a long time, we have stayed hidden behind statistics and numbers. But we are human beings, and now is the time to make ourselves visible as such before health authorities worldwide.’

As of April 14, FINDECHAGAS, together with the WHO/PAHO and other organizations part of the Global Chagas Coalition, as well as other health institutions and alliances, will be publishing content on Chagas disease and affected people through their networks to raise awareness.

Current data and estimates

More than 7 million people affected

30,000 new cases per year

More than 12,000 deaths per year

More than 75 million people are at risk of becoming infected either by vector, or congenitally, orally, through blood transfusion, and organ transplant

The disease is endemic in 21 countries in the Americas, with Argentina, Bolivia, Brazil, Colombia, and Mexico being the countries with the largest number of affected people

In non-endemic areas, the disease is present on all continents, with the largest number of people affected in the United States and Spain.

Reference pages

  • WHO
  • OPS
  • FINDECHAGAS
  • DNDi
  • Global Chagas Coalition
  • Recommendations on COVID-19 and Chagas disease

Photo credit: Felipe Abondano-DNDi

Chagas disease

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License